These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 23532918)

  • 1. Synthesis and in vitro characterisation of ifenprodil-based fluorescein conjugates as GluN1/GluN2B N-Methyl-D-aspartate receptor antagonists.
    Dhilly M; Becerril-Ortega J; Colloc'h N; MacKenzie ET; Barré L; Buisson A; Nicole O; Perrio C
    Chembiochem; 2013 Apr; 14(6):759-69. PubMed ID: 23532918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deconstruction - Reconstruction: Analysis of the Crucial Structural Elements of GluN2B-Selective, Negative Allosteric NMDA Receptor Modulators with 3-Benzazepine Scaffold.
    Ritter N; Korff M; Markus A; Schepmann D; Seebohm G; Schreiber JA; Wünsch B
    Cell Physiol Biochem; 2021 Mar; 55(S3):1-13. PubMed ID: 33656308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subunit arrangement and phenylethanolamine binding in GluN1/GluN2B NMDA receptors.
    Karakas E; Simorowski N; Furukawa H
    Nature; 2011 Jun; 475(7355):249-53. PubMed ID: 21677647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the overlapping binding sites of ifenprodil and EVT-101 in GluN2B-containing NMDA receptors using novel chicken embryo forebrain cultures and molecular modeling.
    Fjelldal MF; Freyd T; Evenseth LM; Sylte I; Ring A; Paulsen RE
    Pharmacol Res Perspect; 2019 Jun; 7(3):e00480. PubMed ID: 31164987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Confocal microscopy imaging of NR2B-containing NMDA receptors based on fluorescent ifenprodil-like conjugates.
    Marchand P; Becerril-Ortega J; Mony L; Bouteiller C; Paoletti P; Nicole O; Barré L; Buisson A; Perrio C
    Bioconjug Chem; 2012 Jan; 23(1):21-6. PubMed ID: 22148315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GluN2B Subunit Labeling with Fluorescent Probes and High-Resolution Live Imaging.
    Perrio C; Nicole O; Buisson A
    Methods Mol Biol; 2017; 1677():171-183. PubMed ID: 28986873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of ifenprodil on GluN1/GluN2B N-methyl-D-aspartate receptor gating.
    Bhatt JM; Prakash A; Suryavanshi PS; Dravid SM
    Mol Pharmacol; 2013 Jan; 83(1):9-21. PubMed ID: 23007555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A conserved structural mechanism of NMDA receptor inhibition: A comparison of ifenprodil and zinc.
    Sirrieh RE; MacLean DM; Jayaraman V
    J Gen Physiol; 2015 Aug; 146(2):173-81. PubMed ID: 26170175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping the high-affinity binding domain of 5-substituted benzimidazoles to the proximal N-terminus of the GluN2B subunit of the NMDA receptor.
    Wee XK; Ng KS; Leung HW; Cheong YP; Kong KH; Ng FM; Soh W; Lam Y; Low CM
    Br J Pharmacol; 2010 Jan; 159(2):449-61. PubMed ID: 20082612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synaptic NMDA receptors in basolateral amygdala principal neurons are triheteromeric proteins: physiological role of GluN2B subunits.
    Delaney AJ; Sedlak PL; Autuori E; Power JM; Sah P
    J Neurophysiol; 2013 Mar; 109(5):1391-402. PubMed ID: 23221411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ifenprodil effects on GluN2B-containing glutamate receptors.
    Amico-Ruvio SA; Paganelli MA; Myers JM; Popescu GK
    Mol Pharmacol; 2012 Dec; 82(6):1074-81. PubMed ID: 22936815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism studies of ifenprodil, a potent GluN2B receptor antagonist.
    Falck E; Begrow F; Verspohl E; Wünsch B
    J Pharm Biomed Anal; 2014 Jan; 88():96-105. PubMed ID: 24042122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The GluN1/GluN2B NMDA receptor and metabotropic glutamate receptor 1 negative allosteric modulator has enhanced neuroprotection in a rat subarachnoid hemorrhage model.
    Zhang Z; Liu J; Fan C; Mao L; Xie R; Wang S; Yang M; Yuan H; Yang X; Sun J; Wang J; Kong J; Huang S; Sun B
    Exp Neurol; 2018 Mar; 301(Pt A):13-25. PubMed ID: 29258835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid beta peptide 1-42 disturbs intracellular calcium homeostasis through activation of GluN2B-containing N-methyl-d-aspartate receptors in cortical cultures.
    Ferreira IL; Bajouco LM; Mota SI; Auberson YP; Oliveira CR; Rego AC
    Cell Calcium; 2012 Feb; 51(2):95-106. PubMed ID: 22177709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Binding Mode Reveals Two Distinct Classes of NMDA Receptor GluN2B-selective Antagonists.
    Stroebel D; Buhl DL; Knafels JD; Chanda PK; Green M; Sciabola S; Mony L; Paoletti P; Pandit J
    Mol Pharmacol; 2016 May; 89(5):541-51. PubMed ID: 26912815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Piroxicam inhibits NMDA receptor-mediated excitotoxicity through allosteric inhibition of the GluN2B subunit: an in silico study elucidating a novel mechanism of action of the drug.
    Mazumder MK; Borah A
    Med Hypotheses; 2014 Dec; 83(6):740-6. PubMed ID: 25459147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ifenprodil prevents glutamate cytotoxicity via polyamine modulatory sites of N-methyl-D-aspartate receptors in cultured cortical neurons.
    Tamura Y; Sato Y; Yokota T; Akaike A; Sasa M; Takaori S
    J Pharmacol Exp Ther; 1993 May; 265(2):1017-25. PubMed ID: 8098757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural changes of regulatory domain heterodimer of N-methyl-D-aspartate receptor subunits GluN1 and GluN2B through the binding of spermine and ifenprodil.
    Tomitori H; Suganami A; Saiki R; Mizuno S; Yoshizawa Y; Masuko T; Tamura Y; Nishimura K; Toida T; Williams K; Kashiwagi K; Igarashi K
    J Pharmacol Exp Ther; 2012 Oct; 343(1):82-90. PubMed ID: 22743575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. II. Evidence for N-methyl-D-aspartate receptor antagonist properties.
    Carter C; Benavides J; Legendre P; Vincent JD; Noel F; Thuret F; Lloyd KG; Arbilla S; Zivkovic B; MacKenzie ET
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1222-32. PubMed ID: 2849669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GluN2B-containing NMDA receptors as possible targets for the neuroprotective and antidepressant effects of fluoxetine.
    Kiss JP; Szasz BK; Fodor L; Mike A; Lenkey N; Kurkó D; Nagy J; Vizi ES
    Neurochem Int; 2012 Jan; 60(2):170-6. PubMed ID: 22197911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.